| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5655571 | Digestive and Liver Disease | 2017 | 6 Pages |
Abstract
In CD patients the LI tends to increase over time, although the use of biological drugs rather than azathioprine or mesalazine seems to be able to reduce the progressive bowel damage.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Giorgia Bodini, Edoardo G. Giannini, Costanza De Maria, Pietro Dulbecco, Manuele Furnari, Elisa Marabotto, Vincenzo Savarino, Edoardo Savarino,